{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:45:17Z","timestamp":1790394317233,"version":"4.1.0"},"publisher-location":"New York, NY","reference-count":35,"publisher":"Springer New York","isbn-type":[{"value":"9781493978151","type":"print"},{"value":"9781493978168","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-1-4939-7816-8_29","type":"book-chapter","created":{"date-parts":[[2018,6,9]],"date-time":"2018-06-09T13:06:41Z","timestamp":1528549601000},"page":"471-484","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Detecting Circulating MicroRNAs as Biomarkers in Alzheimer\u2019s Disease"],"prefix":"10.1007","author":[{"given":"Aidan","family":"Kenny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M.","family":"Jimenez-Mateos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Calero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,8]]},"reference":[{"key":"29_CR1","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","volume":"388","author":"P Scheltens","year":"2016","unstructured":"Scheltens P, Blennow K, Breteler MM et al (2016) Alzheimer\u2019s disease. Lancet 388:505\u2013517","journal-title":"Lancet"},{"key":"29_CR2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.freeradbiomed.2016.10.490","volume":"111","author":"F Domenico Di","year":"2017","unstructured":"Di Domenico F, Tramutola A, Butterfield DA (2017) Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of Alzheimer disease and other selected age-related neurodegenerative disorders. Free Radic Biol Med 111:253\u2013261","journal-title":"Free Radic Biol Med"},{"key":"29_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.52","volume":"5","author":"C Madeira","year":"2015","unstructured":"Madeira C, Lourenco MV, Vargas-Lopes C et al (2015) d-Serine levels in Alzheimer\u2019s disease: implications for novel biomarker development. Transl Psychiatry 5:e561","journal-title":"Transl Psychiatry"},{"key":"29_CR4","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1113\/JP270541","volume":"594","author":"F Yin","year":"2016","unstructured":"Yin F, Sancheti H, Liu Z et al (2016) Mitochondrial function in ageing: coordination with signalling and transcriptional pathways. J Physiol 594:2025\u20132042","journal-title":"J Physiol"},{"key":"29_CR5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/alzrt52","volume":"2","author":"LG Brooks","year":"2010","unstructured":"Brooks LG, Loewenstein DA (2010) Assessing the progression of mild cognitive impairment to Alzheimer\u2019s disease: current trends and future directions. Alzheimers Res Ther 2:28","journal-title":"Alzheimers Res Ther"},{"key":"29_CR6","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1212\/WNL.0b013e3182343314","volume":"77","author":"D Heister","year":"2011","unstructured":"Heister D, Brewer JB, Magda S et al (2011) Predicting MCI outcome with clinically available MRI and CSF biomarkers. Neurology 77:1619\u20131628","journal-title":"Neurology"},{"key":"29_CR7","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.jalz.2013.12.014","volume":"10","author":"DE Barnes","year":"2014","unstructured":"Barnes DE, Cenzer IS, Yaffe K et al (2014) A point-based tool to predict conversion from mild cognitive impairment to probable Alzheimer\u2019s disease. Alzheimers Dement 10:646\u2013655","journal-title":"Alzheimers Dement"},{"key":"29_CR8","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/j.1532-5415.2005.53209.x","volume":"53","author":"C Dufouil","year":"2005","unstructured":"Dufouil C, Fuhrer R, Alperovitch A (2005) Subjective cognitive complaints and cognitive decline: consequence or predictor? The epidemiology of vascular aging study. J Am Geriatr Soc 53:616\u2013621","journal-title":"J Am Geriatr Soc"},{"key":"29_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.arr.2010.04.007","volume":"9","author":"V Frisardi","year":"2010","unstructured":"Frisardi V, Solfrizzi V, Seripa D et al (2010) Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer\u2019s disease. Ageing Res Rev 9:399\u2013417","journal-title":"Ageing Res Rev"},{"key":"29_CR10","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/ncb1104-1054","volume":"6","author":"DJ Selkoe","year":"2004","unstructured":"Selkoe DJ (2004) Cell biology of protein misfolding: the examples of Alzheimer\u2019s and Parkinson\u2019s diseases. Nat Cell Biol 6:1054\u20131061","journal-title":"Nat Cell Biol"},{"key":"29_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1096\/fasebj.12.1.17","volume":"12","author":"L Gasparini","year":"1998","unstructured":"Gasparini L, Racchi M, Binetti G et al (1998) Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer\u2019s disease. FASEB J 12:17\u201334","journal-title":"FASEB J"},{"key":"29_CR12","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/341226a0","volume":"341","author":"CL Joachim","year":"1989","unstructured":"Joachim CL, Mori H, Selkoe DJ (1989) Amyloid beta-protein deposition in tissues other than brain in Alzheimer\u2019s disease. Nature 341:226\u2013230","journal-title":"Nature"},{"key":"29_CR13","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/nm1653","volume":"13","author":"S Ray","year":"2007","unstructured":"Ray S, Britschgi M, Herbert C et al (2007) Classification and prediction of clinical Alzheimer\u2019s diagnosis based on plasma signaling proteins. Nat Med 13:1359\u20131362","journal-title":"Nat Med"},{"key":"29_CR14","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215\u2013233","journal-title":"Cell"},{"key":"29_CR15","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1399-0004.2008.01076.x","volume":"74","author":"AE Erson","year":"2008","unstructured":"Erson AE, Petty EM (2008) MicroRNAs in development and disease. Clin Genet 74:296\u2013306","journal-title":"Clin Genet"},{"key":"29_CR16","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1373\/clinchem.2010.147405","volume":"56","author":"JA Weber","year":"2010","unstructured":"Weber JA, Baxter DH, Zhang S et al (2010) The microRNA spectrum in 12 body fluids. Clin Chem 56:1733\u20131741","journal-title":"Clin Chem"},{"key":"29_CR17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.aca.2011.05.025","volume":"699","author":"M Planell-Saguer de","year":"2011","unstructured":"de Planell-Saguer M, Rodicio MC (2011) Analytical aspects of microRNA in diagnostics: a review. Anal Chim Acta 699:134\u2013152","journal-title":"Anal Chim Acta"},{"key":"29_CR18","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrg3198","volume":"13","author":"CC Pritchard","year":"2012","unstructured":"Pritchard CC, Cheng HH, Tewari M (2012) MicroRNA profiling: approaches and considerations. Nat Rev Genet 13:358\u2013369","journal-title":"Nat Rev Genet"},{"key":"29_CR19","doi-asserted-by":"publisher","first-page":"5003","DOI":"10.1073\/pnas.1019055108","volume":"108","author":"JD Arroyo","year":"2011","unstructured":"Arroyo JD, Chevillet JR, Kroh EM et al (2011) Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A 108:5003\u20135008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"29_CR20","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1373\/clinchem.2010.157198","volume":"57","author":"JS McDonald","year":"2011","unstructured":"McDonald JS, Milosevic D, Reddi HV et al (2011) Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem 57:833\u2013840","journal-title":"Clin Chem"},{"issue":"9","key":"29_CR21","doi-asserted-by":"publisher","first-page":"7224","DOI":"10.1007\/s12035-016-0213-8","volume":"54","author":"Lalit Kumar","year":"2016","unstructured":"Kumar L, Shamsuzzama, Haque R et al (2016) Circular RNAs: the emerging class of non-coding RNAs and their potential role in human neurodegenerative diseases. Mol Neurobiol [Epub ahead of print]","journal-title":"Molecular Neurobiology"},{"key":"29_CR22","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.expneurol.2011.11.013","volume":"235","author":"N Schonrock","year":"2012","unstructured":"Schonrock N, Matamales M, Ittner LM et al (2012) MicroRNA networks surrounding APP and amyloid-beta metabolism\u2014implications for Alzheimer\u2019s disease. Exp Neurol 235:447\u2013454","journal-title":"Exp Neurol"},{"key":"29_CR23","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1172\/JCI78421","volume":"125","author":"I Santa-Maria","year":"2015","unstructured":"Santa-Maria I, Alaniz ME, Renwick N et al (2015) Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau. J Clin Invest 125:681\u2013686","journal-title":"J Clin Invest"},{"key":"29_CR24","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.bbrc.2016.08.067","volume":"483","author":"PH Reddy","year":"2017","unstructured":"Reddy PH, Tonk S, Kumar S et al (2017) A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer\u2019s disease. Biochem Biophys Res Commun 483:1156\u20131165","journal-title":"Biochem Biophys Res Commun"},{"key":"29_CR25","first-page":"263","volume":"1","author":"HM Schipper","year":"2007","unstructured":"Schipper HM, Maes OC, Chertkow HM et al (2007) MicroRNA expression in Alzheimer blood mononuclear cells. Gene Regul Syst Bio 1:263\u2013274","journal-title":"Gene Regul Syst Bio"},{"key":"29_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4137\/BMI.S25132","volume":"10","author":"J Satoh","year":"2015","unstructured":"Satoh J, Kino Y, Niida S (2015) MicroRNA-Seq data analysis pipeline to identify blood biomarkers for Alzheimer\u2019s disease from public data. Biomark Insights 10:21\u201331","journal-title":"Biomark Insights"},{"key":"29_CR27","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.expneurol.2011.11.026","volume":"235","author":"H Geekiyanage","year":"2012","unstructured":"Geekiyanage H, Jicha GA, Nelson PT et al (2012) Blood serum miRNA: non-invasive biomarkers for Alzheimer\u2019s disease. Exp Neurol 235:491\u2013496","journal-title":"Exp Neurol"},{"key":"29_CR28","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3233\/JAD-140756","volume":"42","author":"D Galimberti","year":"2014","unstructured":"Galimberti D, Villa C, Fenoglio C et al (2014) Circulating miRNAs as potential biomarkers in Alzheimer\u2019s disease. J Alzheimers Dis 42:1261\u20131267","journal-title":"J Alzheimers Dis"},{"key":"29_CR29","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.3233\/JAD-132144","volume":"40","author":"L Tan","year":"2014","unstructured":"Tan L, Yu JT, Tan MS et al (2014) Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer\u2019s disease. J Alzheimers Dis 40:1017\u20131027","journal-title":"J Alzheimers Dis"},{"key":"29_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069807","volume":"8","author":"P Kumar","year":"2013","unstructured":"Kumar P, Dezso Z, MacKenzie C et al (2013) Circulating miRNA biomarkers for Alzheimer\u2019s disease. PLoS One 8:e69807","journal-title":"PLoS One"},{"key":"29_CR31","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3233\/JAD-161179","volume":"57","author":"J Riancho","year":"2017","unstructured":"Riancho J, Vazquez-Higuera JL, Pozueta A et al (2017) MicroRNA profile in patients with Alzheimer\u2019s disease: analysis of miR-9-5p and miR-598 in raw and exosome enriched cerebrospinal fluid samples. J Alzheimers Dis 57:483\u2013491","journal-title":"J Alzheimers Dis"},{"key":"29_CR32","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.bbadis.2016.06.001","volume":"1862","author":"S Kumar","year":"2016","unstructured":"Kumar S, Reddy PH (2016) Are circulating microRNAs peripheral biomarkers for Alzheimer\u2019s disease? Biochim Biophys Acta 1862:1617\u20131627","journal-title":"Biochim Biophys Acta"},{"key":"29_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-150451","volume":"49","author":"Y Pan","year":"2016","unstructured":"Pan Y, Liu R, Terpstra E et al (2016) Dysregulation and diagnostic potential of microRNA in Alzheimer\u2019s disease. J Alzheimers Dis 49:1\u201312","journal-title":"J Alzheimers Dis"},{"key":"29_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fnagi.2016.00013","volume":"8","author":"YB Hu","year":"2016","unstructured":"Hu YB, Li CB, Song N et al (2016) Diagnostic value of microRNA for Alzheimer\u2019s disease: a systematic review and meta-analysis. Front Aging Neurosci 8:13","journal-title":"Front Aging Neurosci"},{"key":"29_CR35","doi-asserted-by":"publisher","first-page":"R64","DOI":"10.1186\/gb-2009-10-6-r64","volume":"10","author":"P Mestdagh","year":"2009","unstructured":"Mestdagh P, Van Vlierberghe P, De Weer A et al (2009) A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol 10:R64","journal-title":"Genome Biol"}],"container-title":["Methods in Molecular Biology","Amyloid Proteins"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-7816-8_29","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T08:25:59Z","timestamp":1604391959000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-7816-8_29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9781493978151","9781493978168"],"references-count":35,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-7816-8_29","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}